ConductScience.org, home

Paper36979610

Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers.

Rao Bommi J and 6 others. Biosensors (Basel), 2023. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers. Papers, record 36979610. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979610

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers.
PubMed
Journal
Biosensors (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
2.73
iCite
Revised in PubMed
2024-09-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rao Bommi JJagadeeswarahttps://orcid.org/0000-0002-1909-9624
2Kummari SShekher
3Lakavath KKavitha
4Sukumaran RAReshmi A
5Panicker LRLakshmi R
6Marty JLJean Louishttps://orcid.org/0000-0002-1425-9887
7Yugender Goud KKotagirihttps://orcid.org/0000-0002-0530-0489

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lung NeoplasmsMajor topic
Biosensing TechniquesMajor topic
Male
Humans
Biomarkers, Tumor
Biomarkers

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DST-SERB/RJF/2021/000113Department of Science and TechnologyPubMed

Source PubMed

Download CSV of grants

References219

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122820658Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.Appl Immunohistochem Mol Morphol2013https://conductscience.org/library/papers/22820658PubMed
228637006The effect of CA125 on metastasis of ovarian cancer: old marker new function.Oncotarget2017https://conductscience.org/library/papers/28637006PubMed
334234187A simple label-free electrochemical sensor for sensitive detection of alpha-fetoprotein based on specific aptamer immobilized platinum nanoparticles/carboxylated-graphene oxide.Sci Rep2021https://conductscience.org/library/papers/34234187PubMed
428343975
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Lancet Oncol2017https://conductscience.org/library/papers/28343975PubMed
534736103An ultrasensitive carcinoembryonic antigen electrochemical aptasensor based on 3D DNA nanoprobe and Exo III.Biosens Bioelectron2022https://conductscience.org/library/papers/34736103PubMed
612928122Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).Lung Cancer2003https://conductscience.org/library/papers/12928122PubMed
736531979
Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study.
Breast J2022https://conductscience.org/library/papers/36531979PubMed
815317891Circulating tumor cells, disease progression, and survival in metastatic breast cancer.N Engl J Med2004https://conductscience.org/library/papers/15317891PubMed
920728210
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Lancet2010https://conductscience.org/library/papers/20728210PubMed
1011275721Assessment of fibrin-fibrinogen degradation products (Accu-Dx) test in bladder cancer patients.Eur Urol2001https://conductscience.org/library/papers/11275721PubMed
1115591335A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.N Engl J Med2004https://conductscience.org/library/papers/15591335PubMed
1233044104Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection.Expert Rev Mol Diagn2020https://conductscience.org/library/papers/33044104PubMed
1331803255Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors.Ther Adv Med Oncol2019https://conductscience.org/library/papers/31803255PubMed
1420709523Diseases as network perturbations.Curr Opin Biotechnol2010https://conductscience.org/library/papers/20709523PubMed
1529950525Lung cancer stage-shift following a symptom awareness campaign.Thorax2018https://conductscience.org/library/papers/29950525PubMed
1631088185Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.Int J Biol Markers2019https://conductscience.org/library/papers/31088185PubMed
1730119234Current trends and emerging diagnostic techniques for lung cancer.Biomed Pharmacother2018https://conductscience.org/library/papers/30119234PubMed
187825587Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.Am J Hum Genet1995https://conductscience.org/library/papers/7825587PubMed
193037205Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer.Med Oncol Tumor Pharmacother1987https://conductscience.org/library/papers/3037205PubMed
2017440939Molecular PCA3 diagnostics on prostatic fluid.Prostate2007https://conductscience.org/library/papers/17440939PubMed

See all 219 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
41459192Sensitive immunosensing of melanoma biomarker based on enhanced electrochemiluminescence via electronic metal-support interactions.Front Chem2025https://conductscience.org/library/papers/41459192PubMed
41326503Knowledge attitude and practice regarding cancer screening among Chinese medical students.Sci Rep2025https://conductscience.org/library/papers/41326503PubMed
40842877Circulating long noncoding RNA: New frontiers in biomarker research for mood disorders.Genom Psychiatry2025https://conductscience.org/library/papers/40842877PubMed
40826140Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives.Eur J Med Res2025https://conductscience.org/library/papers/40826140PubMed
40277535Microbial Transcription Factor-Based Biosensors: Innovations from Design to Applications in Synthetic Biology.Biosensors (Basel)2025https://conductscience.org/library/papers/40277535PubMed
39309878LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets.Heliyon2024https://conductscience.org/library/papers/39309878PubMed
39066110Unveiling Colorectal Cancer Biomarkers: Harnessing Biosensor Technology for Volatile Organic Compound Detection.Sensors (Basel)2024https://conductscience.org/library/papers/39066110PubMed
38761260Artificial intelligence assisted diagnosis of early tc markers and its application.Discov Oncol2024https://conductscience.org/library/papers/38761260PubMed
38493183Redox proteomics of PANC-1 cells reveals the significance of HIF-1 signaling protein oxidation in pancreatic ductal adenocarcinoma pathogenesis.J Transl Med2024https://conductscience.org/library/papers/38493183PubMed
38362685Evolution and Trends of Aptamers in Cancer Research: A Bibliometric Analysis of the Literature over the Last Decade.Curr Med Chem2025https://conductscience.org/library/papers/38362685PubMed
38007511Radiogenomic analysis of cellular tumor-stroma heterogeneity as a prognostic predictor in breast cancer.J Transl Med2023https://conductscience.org/library/papers/38007511PubMed
37849007Colonic medullary carcinoma: an exceedingly rare type of colorectal malignancy: a case report and review of the literature.J Med Case Rep2023https://conductscience.org/library/papers/37849007PubMed
37730928Quantitative measurement of CA 15-3 cancer biomarker using an electrochemical aptasensor based on the electrodeposition of Au thin film on cauliflower-like rGO-MoS2 nanocomposite.Mikrochim Acta2023https://conductscience.org/library/papers/37730928PubMed

Download CSV of cited by

Genes23

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CALCA796PubTator's text mininghttps://conductscience.org/library/genes/796NCBI Gene
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
CGB593659PubTator's text mininghttps://conductscience.org/library/genes/93659NCBI Gene
CTAG1B1485PubTator's text mininghttps://conductscience.org/library/genes/1485NCBI Gene
DNTT1791PubTator's text mininghttps://conductscience.org/library/genes/1791NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ENO22026PubTator's text mininghttps://conductscience.org/library/genes/2026NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
KRT193880PubTator's text mininghttps://conductscience.org/library/genes/3880NCBI Gene
MUC14582PubTator's text mininghttps://conductscience.org/library/genes/4582NCBI Gene
MUC1694025PubTator's text mininghttps://conductscience.org/library/genes/94025NCBI Gene

See all 23 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36979610

GET https://conductscience.org/api/papers/v1/36979610/references?page=2